R&D Transforming drug development with statistical methodologies The product development lifecycle is long and challenging.
Market Access Pharmacogenomics and IVDR: Overcoming transition challenges In recent years, the in vitro diagnostics (IVD) regulatory landscape in Europe has changed and we are now in the transition from IVD Directive 98/79/EC (IVDD) to In Vitro
R&D A new dawn of the genomic age: five areas set to be transfor... 2022 was a banner year for genomics.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
